Nuveen Asset Management, LLC Graphite Bio, Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.47 - $3.38 $98,152 - $134,314	39,738 New	39,738 $103,000
Q2 2022 Aug 15, 2022	SELL	$2.14 - $5.23 $116,005 - $283,507	-54,208 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.1 - $13.06 $156,371 - $400,432	30,661 Added 130.21%	54,208 $373,000
Q4 2021 Feb 14, 2022	SELL	$8.41 - $16.71 $90,525 - $179,866	-10,764 Reduced 31.37%	23,547 $240,000
Q3 2021 Nov 12, 2021	BUY	$15.81 - $28.39 $542,456 - $974,089	34,311 New	34,311 $562,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.